MUC1 and COVID-19: In a previously letter, Frix et al [1] retrospectively compared KL-6 serum levels among a cohort of 83 COVID-19 patients, and versus two other groups, one of healthy subjects (n = 70) and the other suffering from interstitial lung diseases (n = 31).